erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the...
the senate included a provision similar to cusack's bill in its omnibus health care overhaul legislation passed last november, according to sen..
he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies.